Harrow

Harrow Health, Inc. (NASDAQ: HROW) is a healthcare company focused on ophthalmology. The company owns ImprimisRx, a leading ophthalmology outsourcing and compounding business in the U.S., and Visionology, a direct-to-consumer ophthalmic care subsidiary focused on chronic eye diseases. Harrow Health also holds significant stakes in Eton Pharmaceuticals, Surface Ophthalmics, and Melt Pharmaceuticals, all of which originated as Harrow Health subsidiaries. Additionally, Harrow Health holds royalty rights to four clinical-stage drug candidates being developed by Surface Ophthalmics and Melt Pharmaceuticals.